Trends in Overactive Bladder Prescriptions from 2020 to 2022
Gynecology & Reproductive Health · 30.06.2026 · 10 (3)
DOI: 10.33425/2639-9342.1297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gynecology & Reproductive Health, online erschienen am 30.06.2026. Verfasst von Sarah Ashmore und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Importance: There is growing concern regarding the risk of cognitive impairment with anticholinergics to treat overactive bladder (OAB). In 2021, updated clinical guidelines cautioned the use of anticholinergic especially in elderly patients and vibegron became the second available Beta-3 agonist medication.
Objective
The primary objective of this study was to examine OAB prescribing patterns from 2020 to 2022. Study Design: This was a retrospective study at two academic centers between January 2020 and December 2022. Female patients at least 18 years old diagnosed with OAB and newly prescribed anticholinergic or Beta-3 for OAB were included. OAB diagnosis was identified using ICD-10 codes and the electronic medical record was queried for new OAB medication prescriptions in the health system. Patient demographics and provider specialty were abstracted from the medical record.
Results
Between 2020 and 2022, 12,162 patients were prescribed a new anticholinergic or Beta-3 medication. Older, white patients were more likely to be prescribed Beta-3 medications (p
Zitieren
APA
Ashmore, S., Mueller, M. G., Kenton, K., MA, J. S., Sarkar, P., & Brown, O. (2026). Trends in Overactive Bladder Prescriptions from 2020 to 2022. Gynecology & Reproductive Health, 10(3). https://doi.org/10.33425/2639-9342.1297
Vancouver
Ashmore S, Mueller MG, Kenton K, MA JS, Sarkar P, Brown O. Trends in Overactive Bladder Prescriptions from 2020 to 2022. Gynecology & Reproductive Health. 2026;10(3). doi:10.33425/2639-9342.1297
BibTeX
@article{Ashmore2026,
author = {Ashmore, Sarah and Mueller, Margaret G and Kenton, Kimberly and MA, Jinxuan Shi and Sarkar, Prottusha and Brown, Oluwateniola},
title = {Trends in Overactive Bladder Prescriptions from 2020 to 2022},
journal = {Gynecology & Reproductive Health},
year = {2026},
volume = {10},
number = {3},
doi = {10.33425/2639-9342.1297}
}
EUVIMED